Pancreatic cancer disparities in African Americans

Pancreas

Volumn 44, Issue 4, 2015, Pages 522-527

  Khawja, Shumaila N ^a   Mohammed, Somala ^a   Silberfein, Eric J ^a   Musher, Benjamin L ^a   Fisher, William E ^a   Van Buren, George ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

African American; disparities; pancreatic cancer

Indexed keywords

AFRICAN AMERICAN; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; EVIDENCE BASED PRACTICE; HEALTH CARE DISPARITY; HUMAN; INVESTIGATIVE PROCEDURES; MEDLINE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; ADENOCARCINOMA; EPIDEMIOLOGY; ETHNOLOGY; HEALTH DISPARITY; INCIDENCE; MORTALITY; PANCREATIC NEOPLASMS; RISK FACTOR; UNITED STATES;

ADENOCARCINOMA; AFRICAN AMERICANS; COMBINED MODALITY THERAPY; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; PANCREATIC NEOPLASMS; RISK FACTORS; UNITED STATES;

EID: 84928493162     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000323     Document Type: Review

References (61)

1. RiesLA, EisnerMP,KosaryCL, et al., eds. SEERCancer StatisticsReview, 1973-1999. National Cancer Institute/SEERWeb site. 2002. Available at: http://seer.cancer.gov/archive/csr/1973-1999/. Accessed June 8, 2013.
2. Howlader N, Noone AM, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2010. National Cancer Institute/SEERWebsite. 2013. Available at: http://seer.cancer.gov/csr/1975-2010/. Accessed June 8, 2013.
3. Hidalgo M. Pancreatic cancer. N Engl JMed. 2010;362:1605-1617.
4. Murphy MM, Simons JP, Hill JS, et al. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma. Cancer. 2009;115:3979-3990.
5. Riall TS, TownsendCMJr,Kuo YF, et al. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process. Cancer. 2010;116:930-939.
6. Ries LA, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. National Cancer Institute/SEERWeb site. 2008. Available at: http://seer.cancer.gov/archive/csr/1975-2005/. Accessed June 8, 2013.
7. Cancer Facts & Figures, 2010. American Cancer Society Web site. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026238.pdf. Accessed June 8, 2013.
8. Pulte D, RedanielMT, Brenner H, et al. Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing? Ann Oncol. 2012;23:2428-2434.
9. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93.
10. Steyerberg EW, Earle CC, Nedille BA, et al. Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 2005;23: 510-517.
11. Du XL, Meyer TE, Franzini L. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer. 2007;109:2161-2170.
12. Eloubeidi MA, Desmond RA, Wilcox CM, et al. Prognostic factors for survival in pancreatic cancer: a population-based study. Am J Surg. 2006; 192:322-329.
13. Doubeni CA, Field CS, Buist DS, et al. Racial differences in tumor stage and survival for patients with colorectal cancer in an insured population. Cancer. 2007;109:612-620.
14. Lau M, Lee A, El-SeragHB. Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol. 2006;101:2485-2492.
15. Zell JA, Rhee JM, Ziogas A, et al. Race, socioeconomic status, treatment and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007;16:546-552.
16. Virnig BA, Baxter NN, Habermann EB, et al. A matter of race: early-versus late-stage cancer diagnosis. Health Aff. 2009;28:160-168.
17. Lem JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237:74-85.
18. Fitzgerald TL, Bradley CJ, Dahman B, et al. Gastrointestinal malignancies: when does race matter? J Am Coll Surg. 2009;209:645-652.
19. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
20. Clegg LX, Li FP, Hankey BF, et al. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med. 2002; 162:1985-1993.
21. Niu X, Pawlish KS, Roche LM. Cancer survival disparities by race/ethnicity and socioeconomic status in New Jersey. J Health Care Poor Underserved. 2010;21:144-160.
22. Wray CJ, Castro-Echeverry E, Silberfein EJ, et al. A multi-institutional study of pancreatic cancer in Harris County, Texas: race predicts treatment and survival. Ann Surg Oncol. 2012;19:2776-2781.
23. Abraham A, Al-Refaie WB, Parsons HM, et al. Disparities in pancreas cancer care. Ann Surg Oncol. 2013;20:2078-2087.
24. Singal V, Singal AK, Kuo YF. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis. J Cancer Res Clin Oncol. 2012;138:715-722.
25. Chang KJ, Parasher G, Christie C, et al. Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups. Cancer. 2005;103:349-357.
26. Murphy MM, Simons JP, Ng SC, et al. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16:2968-2977.
27. Shavers VL, Harlan LC, JacksonM, et al. Racial/ethnic patterns of care for pancreatic cancer. J Palliat Med. 2009;12:623-630.
28. Anderson KE, Potter JD, Mack TM. Pancreatic cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 1996: 725-771.
29. Ji BT, ChowWH, Dai Q, et al. Cigarette smoking and alcohol consumption and the risk of pancreatic cancer: a case-control study in Shanghai, China. Cancer Causes Control. 1995;6:369-376.
30. Fuchs CS, Colditz GA, StampferMJ, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med. 1996;156: 2255-2260.
31. Harnack LJ, Anderson KE, Zheng W, et al. Smoking, alcohol, coffee, and tea intake and incidence of cancer of the exocrine pancreas: the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 1997;6: 1081-1086.
32. Arnold LD, Patel AV, Yan Y, et al. Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity? Cancer Epidemiol Biomarkers Prev. 2009;18:2397-2405.
33. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. JAMA. 1995;273:1605-1609.
34. Friedman GD, van den Eeden SK. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol. 1993;22:30-37.
35. Shibata A, Mack TM, Paganini-Hill A, et al. A prospective study of pancreatic cancer in the elderly. Int J Cancer. 1994;58:46-49.
36. Hakulinen T, Lehtimäki L, Lehtonen M, et al. Cancer morbidity among two male cohorts with increased alcohol consumption in Finland. J Natl Cancer Inst. 1974;52:1711-1714.
37. Adelstein A, White G. Alcoholism and mortality. Popul Trends. 1976;6:7-13.
38. Klatsky AL, Friedman GD, Siegelaub AB. Alcohol and mortality: a ten-year Kaiser-Permanente experience. Ann Intern Med. 1981;95: 139-145.
39. Heuch I, Kvale G, Jacobsen BK, et al. Use of alcohol, tobacco and coffee, and risk of pancreatic cancer. Br J Cancer. 1983;48:637-643.
40. Cuzick J, Babiker AG. Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int J Cancer. 1989;43:415-421.
41. OlsenGW,Mandel JS, Gibson RW, et al. A case-control study of pancreatic cancer and cigarettes, alcohol, coffee and diet. Am J Public Health. 1989;79:1016-1019.
42. Adami HO, McLaughlin JK, Hsing AW, et al. Alcoholism and cancer risk: a population-based cohort study. Cancer Causes Control. 1992; 3:419-425.
43. Tønnesen H, Møller H, Andersen JR, et al. Cancer morbidity in alcohol abusers. Br J Cancer. 1994;69:327-332.
44. Partanen TJ, Vainio HU, Ojajärvi IA, et al. Pancreas cancer, tobacco smoking and consumption of alcoholic beverages: a case-control study. Cancer Lett. 1997;116:27-32.
45. Schmidt W, de Lint J. Causes of death of alcoholics. J Stud Alcohol. 1972;33:171-185.
46. Monson RR, Lyon JL. Proportional mortality among alcoholics. Cancer. 1975;36:1077-1079.
47. Dean G, MacLennan R, McLoughlin H, et al. Causes of death of blue-collar workers at a Dublin brewery, 1954-73. Br J Cancer. 1979; 40:581-589.
48. Robinette CD, Hrubec Z, Fraumeni JF Jr. Chronic alcoholism and subsequent mortality in World War II veterans. Am J Epidemiol. 1979; 109:687-700.
49. Jensen OM. Cancer Morbidity and Causes of Death Among Danish Brewery Workers. IARC: Lyon, France; 1980.
50. Schmidt W, Popham RE. The role of drinking and smoking in mortality from cancer and other causes in male alcoholics. Cancer. 1981;47: 1031-1041.
51. Tavani A, Pregnolato A, Negri E, et al. Alcohol consumption and risk of pancreatic cancer. Nutr Cancer. 1997;27:157-161.
52. Talamini G, Bassi C, Falconi M, et al. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci. 1999;44: 1303-1311.
53. Wong SL, Gu N, Banerjee M, et al. The impact of socioeconomic status on cancer care and survival. J Clin Oncol. 2011;29(suppl Abstr 6004).
54. Gibney EM, Doshi MD, Hartmann EL, et al. Health insurance status of US living kidney donors. Clin J Am Soc Nephrol. 2010; 5:912-916.
55. Silverman DT, Hoover RN, Brown LM, et al. Why do black Americans have a higher risk of pancreatic cancer than white Americans? Epidemiology. 2003;14:45-54.
56. van Loon AJ, Brug J, Goldbohm RA, et al. Differences in cancer incidence and mortality among socio-economic groups. Scand J Soc Med. 1995;23: 110-120.
57. Kogevinas M, Pearce N, Susser M, et al., eds. Social Inequalities and Cancer. Lyon, France: IARC Scientific Publications No.138; 1997.
58. Lund MJ, Butler EN, Hair BY, et al. Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report. Cancer. 2010;116:2549-2559.
59. Swede H, Gregorio DI, Tannenbaum SH, et al. Prevalence and prognostic role of triple-negative breast cancer by race: a surveillance study. Clin Breast Cancer. 2011;11:332-341.
60. Pernick NL, Sarkar FH, Philip PA, et al. Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians. Pancreas. 2003;26:28-32.
61. Biankin AV, Waddell N, Kassahn KS, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012;491: 399-405.